The association between diabetes metabolic control and drug adherence in an indigent population.
about
Factors associated with first-fill adherence rates for diabetic medications: a cohort studyAdherence to oral hypoglycemic agents in Hawaii.Diabetes in African AmericansDefining the role of medication adherence in poor glycemic control among a general adult population with diabetesAppointment adherence and disparities in outcomes among patients with diabetesIs the quality of data in an electronic medical record sufficient for assessing the quality of primary care?A Comparison of Data Driven-based Measures of Adherence to Oral Hypoglycemic Agents in Medicaid PatientsClinical outcomes and adherence to medications measured by claims data in patients with diabetesTreating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study.Use of the emergency department for less-urgent care among type 2 diabetics under a disease management program.Evaluation of the chronic disease management program for appropriateness of medication adherence and persistence in hypertension and type-2 diabetes patients in Korea.Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) remindersLong-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation.Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach.Evaluation of Therapeutic Effectiveness of Prescribed Medications in Patients with Type 2 Diabetes Mellitus: Findings from a Tertiary Care Hospital, Lahore, Pakistan.A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma.Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria.Correlates of self-care in low-income African American and Latino patients with diabetes.Differing effects of metformin on glycemic control by race-ethnicity.Review: relation between quality-of-care indicators for diabetes and patient outcomes: a systematic literature review.Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based StudyAdherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.How to use pharmacy claims data to measure patient nonadherence? The example of oral diabetics in therapy of type 2 diabetes mellitus.Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.Diabetes burden and diabetes distress: the buffering effect of social support.Design of the Lifestyle Improvement through Food and Exercise (LIFE) study: a randomized controlled trial of self-management of type 2 diabetes among African American patients from safety net health centers.Refill adherence to oral hypoglycemic agents and glycemic control in veterans.Feasibility and usability of a text message-based program for diabetes self-management in an urban African-American population.The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia.Race and medication adherence and glycemic control: findings from an operational health information exchangeTreatment non-adherence among patients with poorly controlled type 2 diabetes in ambulatory care settings in southwestern Nigeria.Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study.How patient cost-sharing trends affect adherence and outcomes: a literature review.Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysisMeasurements of medication adherence in diabetic patients with poorly controlled HbA(1c)Race/ethnicity and nonadherence to prescription medications among seniors: results of a national studyMedication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement.The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.Alcohol consumption is inversely associated with adherence to diabetes self-care behaviours.
P2860
Q24646987-38DCAD1C-4912-4CEF-8A22-89946D84E093Q25257800-EC1A68B1-1F17-41F9-A189-897960CE32A9Q28394087-EB0C8FB5-9086-4BAE-A457-F95D95F8C021Q28543287-4D99C7EA-6144-42B6-925A-CAA018E17427Q30438349-BA3C1DF9-BB52-49DC-9810-D67DF7F876F6Q30681480-B9196E4D-B92B-4B44-940A-94D095473FDFQ30947003-CBD04D6B-C187-43C2-85E9-035FAE0671A6Q30977056-FF8E8616-24DE-479C-B62F-A9C19979FDB0Q33481950-7EE271D9-CA64-4885-BFB5-1A705366D426Q33517484-46EE64C9-CE6F-48B9-8134-A6AFA9CE3160Q33621412-D027D25C-22F1-41E3-B697-DEB8629FCEC4Q33707663-6B7AE310-BBE1-4D03-B5A1-BB22C7C90288Q33789527-D3451814-87D6-4395-8AE1-A209D15F9D8BQ33859865-A0045B63-7C7F-4798-B689-A74381024A23Q33880856-F19C0F40-22B7-4D66-A57D-6653F79DACA9Q33900384-887AB4AF-F392-4451-881E-39052D494458Q34050099-0B13D1F3-212C-4638-96EB-0C30CB1C098DQ34069718-BD4EA095-A4EF-4253-9BDE-41AA1B04185CQ34127698-066CAD12-E120-4583-AD6C-CE2C381938D0Q34130997-25608C19-8C20-40A5-8E81-A9C7E1F8A22EQ34181877-5A7D9F68-013D-41EE-BFDB-6C4BA5E40248Q34189448-49254868-16A0-4B31-99B7-CC8C7D157241Q34307167-77AB8B93-0102-4A3B-80E5-828B097441FAQ34344393-171194C7-B8AB-4A7C-8AA7-3D724DD37C17Q34553412-50FFC101-58E8-4F8B-868A-3B67A3DA828DQ34598307-D29D2D3F-CA06-42EF-8D76-8B335C2A347FQ34978257-58B4B5D8-1712-488D-AE68-4645B636EAA6Q35052411-F5828547-FEAF-4910-A090-0F0CF6D712BAQ35529682-7E86FBAB-CED0-4A06-8F38-A51607F5EC31Q35536685-F737D79C-30CD-4F3B-8CCC-5A8AC09EC142Q35625452-90A00E8E-7ECB-4A02-B1AC-350810B2B4C7Q35665166-1902481F-8D93-4DC2-9C32-F9BFE48AA877Q35674552-F8DA578E-2F16-45F0-A76B-B0C4F46B1348Q35752951-9EC06AB5-FED3-4C27-9276-18C3B85FF836Q35830021-7F1C25C9-8C10-4779-9B6A-191DBCD5E4CDQ36224463-E94A5F63-37BB-4E9C-A554-713FAAC135F6Q36416879-A5B9BED3-BD6F-40CF-B13D-2EBDC0EE809AQ36426795-CB0F3247-DF2E-43E5-992F-6F19FCECC7A3Q36432150-D827E1F2-9FC5-4E48-BA35-17920BA21F58Q36453704-501AB1D5-5AD6-4C51-B41F-31979E4EB7D3
P2860
The association between diabetes metabolic control and drug adherence in an indigent population.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The association between diabet ...... nce in an indigent population.
@ast
The association between diabet ...... nce in an indigent population.
@en
type
label
The association between diabet ...... nce in an indigent population.
@ast
The association between diabet ...... nce in an indigent population.
@en
prefLabel
The association between diabet ...... nce in an indigent population.
@ast
The association between diabet ...... nce in an indigent population.
@en
P2093
P1433
P1476
The association between diabet ...... nce in an indigent population.
@en
P2093
Joel M Schectman
John D Voss
Mohan M Nadkarni
P304
P356
10.2337/DIACARE.25.6.1015
P407
P577
2002-06-01T00:00:00Z